AI
AMPH icon

AdvisorShares Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

AdvisorShares Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,200
Closed -$294K – 234
2022
Q1 		$294K Buy
+8,200
New +$233K 0.05% 142

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AdvisorShares Investments's AMPH Position: Q2 2022 in Review

AdvisorShares Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2022, closing a stake of 8,200 shares — an estimated $294K sold.

AdvisorShares Investments first reported a position in AMPH in Q1 2022 and held it in 1 quarter. The position peaked at $294K in Q1 2022. 223 funds tracked by Wall St. Rank hold AMPH as of Q2 2022.

  • AdvisorShares Investments reported no remaining Amphastar Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • AdvisorShares Investments sold 8,200 Amphastar Pharmaceuticals shares in Q2 2022, an estimated $294K.
  • AdvisorShares Investments first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • AdvisorShares Investments's Amphastar Pharmaceuticals position peaked at $294K in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2022.

Based on AdvisorShares Investments's 13F filing for Q2 2022, filed 8 Aug 2022.